$MNKD $MNKD Once again it shows us that Afrezza is not commercially viable in the USA. SNY was right. But, the pumpers will continue to say SNY sandbagged, the shorts are keeping the pps down and BP is conspiring against MNKD. How about this: The medical community rejects inhaled insulin.
  • 1
  • 5